TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.

Akihiro Ohba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.